RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,662,910 | -24.3% | 761,908 | -14.9% | 0.00% | -50.0% |
Q2 2023 | $16,736,987 | +17.8% | 895,026 | +15.6% | 0.00% | 0.0% |
Q1 2023 | $14,206,113 | -5.4% | 774,175 | +2.1% | 0.00% | 0.0% |
Q4 2022 | $15,012,063 | -19.2% | 758,185 | -1.8% | 0.00% | -33.3% |
Q3 2022 | $18,581,000 | -2.4% | 772,275 | -26.0% | 0.00% | +50.0% |
Q2 2022 | $19,044,000 | -18.0% | 1,043,552 | -1.2% | 0.00% | -33.3% |
Q1 2022 | $23,222,000 | -36.8% | 1,055,957 | +5.6% | 0.00% | -40.0% |
Q4 2021 | $36,725,000 | +54.9% | 999,873 | +30.9% | 0.01% | +66.7% |
Q3 2021 | $23,714,000 | +115.2% | 763,744 | +120.3% | 0.00% | +200.0% |
Q2 2021 | $11,022,000 | +733.1% | 346,729 | +481.9% | 0.00% | – |
Q1 2021 | $1,323,000 | -29.4% | 59,583 | -37.2% | 0.00% | – |
Q4 2020 | $1,874,000 | +2783.1% | 94,915 | +4617.4% | 0.00% | – |
Q3 2020 | $65,000 | -71.6% | 2,012 | -74.6% | 0.00% | – |
Q2 2020 | $229,000 | +4480.0% | 7,919 | +3617.8% | 0.00% | – |
Q1 2020 | $5,000 | -93.9% | 213 | -92.7% | 0.00% | – |
Q4 2019 | $82,000 | – | 2,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |